BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8230593)

  • 1. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
    MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
    JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of patients with neurofibromatosis 2.
    MacCollin M; Ramesh V; Jacoby LB; Louis DN; Rubio MP; Pulaski K; Trofatter JA; Short MP; Bove C; Eldridge R
    Am J Hum Genet; 1994 Aug; 55(2):314-20. PubMed ID: 7913580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
    MacCollin M
    Brain Dev; 1995; 17(4):231-8. PubMed ID: 7503383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree.
    Sainio M; Strachan T; Blomstedt G; Salonen O; Setälä K; Palotie A; Palo J; Pyykkö I; Peltonen L; Jääskeläinen J
    Neurology; 1995 Jul; 45(7):1314-22. PubMed ID: 7617190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF2 gene in neurofibromatosis type 2 patients.
    Zucman-Rossi J; Legoix P; Der Sarkissian H; Cheret G; Sor F; Bernardi A; Cazes L; Giraud S; Ollagnon E; Lenoir G; Thomas G
    Hum Mol Genet; 1998 Dec; 7(13):2095-101. PubMed ID: 9817927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts.
    Pykett MJ; Murphy M; Harnish PR; George DL
    Hum Mol Genet; 1994 Apr; 3(4):559-64. PubMed ID: 8069298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
    Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
    Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular biological analysis of neurofibromatosis type 2 gene].
    Ichimura K; Yuasa Y
    Nihon Rinsho; 1993 Sep; 51(9):2462-6. PubMed ID: 8411729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic variability in two families with novel splice-site and frameshift NF2 mutations.
    Mautner VF; Baser ME; Kluwe L
    Hum Genet; 1996 Aug; 98(2):203-6. PubMed ID: 8698343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exon scanning for mutation of the NF2 gene in schwannomas.
    Jacoby LB; MacCollin M; Louis DN; Mohney T; Rubio MP; Pulaski K; Trofatter JA; Kley N; Seizinger B; Ramesh V
    Hum Mol Genet; 1994 Mar; 3(3):413-9. PubMed ID: 8012353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.
    Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR
    J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
    Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
    Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly polymorphic dinucleotide repeat at the NF2 gene.
    Bourn D; Strachan T
    Hum Genet; 1995 Jun; 95(6):712. PubMed ID: 7789960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
    Stokowski RP; Cox DR
    Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
    Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
    Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eleven novel mutations in the NF2 tumour suppressor gene.
    Bourn D; Evans G; Mason S; Tekes S; Trueman L; Strachan T
    Hum Genet; 1995 May; 95(5):572-4. PubMed ID: 7759081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.